Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Vitamin C

This article was originally published in The Tan Sheet

Executive Summary

Exhibits "prooxidant" as well as antioxidant effects, Ian Podmore, PhD, et al., University of Leicester (U.K.), report in the April 9 issue of Nature. After daily administration of 500 mg ascorbic acid to 30 participants for six weeks, researchers used gas chromatography and mass spectrometry to measure levels of oxygen radicals in two of the subjects' peripheral blood lymphocytes. Levels of one, 8-oxoguanine, decreased after supplementation relative to baseline and placebo, while another, 8-oxoadenine, increased. The study notes an increase in oxygen radicals such as 8-oxoadenine may cause biomolecular damage, possibly increasing the risk of cancer, rheumatoid arthritis and atherosclerosis. The researchers report their "discovery" of an increase of "a potentially mutagenic lesion" could be of "some concern, although at doses of less than 500 mg per day the antioxidant effect may predominate." The Council for Responsible Nutrition refutes the findings...

You may also be interested in...



Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

People In Brief

Perrigo promotes in pricing, planning

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

UsernamePublicRestriction

Register

ID1132298

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel